Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, HIV Vaccine Design & Development Teams—RFP-NIAID-DAIDS-BAA-06-19—ZAI1-CCH-A-C1.
Date: February 21-22, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Silver Springs, 8727 Colesville Road, Silver Spring, MD 20910.
Contact Person: Clayton C. Huntley, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities; National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 496-2550, email@example.com.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Immune Response to Listeria Infection—ZAI1-PA-I-M2.
Date: February 22, 2006.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 402-7098, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)Start Signature
Dated: January 30, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1025 Filed 2-2-06; 8:45am]
BILLING CODE 4140-01-M